SCHEMBL6565768

SCHEMBL6565768

COC(=O)c1cc(NC(=O)Nc2ccc(OC)c(OC)c2)ccc1OCc1ccc(C(C)(C)C)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 2/20 0.53
MAPT P10636 6/20 0.52
MEN1 O00255 4/20 0.52
KMT2A Q03164 4/20 0.52
NR1H4 Q96RI1 2/20 0.52
RAB9A P51151 3/20 0.49
POLB P06746 1/20 0.49
LMNA P02545 4/20 0.47
GAA P10253 2/20 0.47
SMN1; SMN2 Q16637 4/20 0.46
NPC1 O15118 1/20 0.46
MAPK1 P28482 1/20 0.46
STAT1 P42224 1/20 0.46
HTT P42858 1/20 0.46
KDM4E B2RXH2 2/20 0.46
ALDH1A1 P00352 2/20 0.46
HPGD P15428 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
RAF1 P04049 2/20 0.45
BRAF P15056 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6566760 0.90 NR1H4 (0.50) TRPV1MAPTMEN1KMT2ANR1H4
SCHEMBL6567623 0.85 MEN1 (0.52) MAPTMEN1KMT2ARAB9APOLB
SCHEMBL6567936 0.81 MAPT (0.54) MAPTMEN1KMT2ARAB9APOLB
SCHEMBL6564446 0.81 MAPT (0.52) TRPV1MAPTMEN1KMT2ANR1H4
SCHEMBL6566692 0.78 MEN1 (0.61) MEN1KMT2ARAB9APOLBLMNA
SCHEMBL12952790 0.78 APP (0.51) MAPTRAB9ALMNASMN1; SMN2NPC1
SCHEMBL6564646 0.78 RXRA (0.47) MAPTRAB9ALMNAGAASMN1; SMN2
SCHEMBL2294409 0.78 FFAR4 (0.56) MEN1KMT2ARAB9ALMNASMN1; SMN2
SCHEMBL5927325 0.78 PTGER1 (0.51) RAB9ANPC1L3MBTL1
SCHEMBL6567673 0.78 MAPT (0.63) TRPV1MAPTMEN1KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-12-23 US disclosed
EP-1437344-A1 BENZENE DERIVATIVES,PROCESS FOR PREPARING THE SAME AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2004-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof HRH4, HRH2, HRH1 TRPV1 45/4885MAPT 4743/4885MEN1 4143/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.